Comerica Bank lifted its position in Ambev S.A. (NYSE:ABEV – Get Rating) by 3.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 310,494 shares of the company's stock after purchasing an additional 10,784 shares during the quarter. Comerica Bank's holdings in Ambev were worth $879,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. YorkBridge Wealth Partners LLC raised its stake in shares of Ambev by 3.8% in the third quarter. YorkBridge Wealth Partners LLC now owns 101,551 shares of the company's stock valued at $287,000 after purchasing an additional 3,684 shares in the last quarter. Park Avenue Securities LLC raised its stake in Ambev by 10.0% during the second quarter. Park Avenue Securities LLC now owns 41,082 shares of the company's stock worth $103,000 after acquiring an additional 3,727 shares in the last quarter. Scotia Capital Inc. raised its stake in Ambev by 0.3% during the second quarter. Scotia Capital Inc. now owns 1,270,909 shares of the company's stock worth $3,190,000 after acquiring an additional 3,727 shares in the last quarter. Jarislowsky Fraser Ltd raised its stake in Ambev by 11.6% during the second quarter. Jarislowsky Fraser Ltd now owns 38,153 shares of the company's stock worth $95,000 after acquiring an additional 3,960 shares in the last quarter. Finally, Moors & Cabot Inc. raised its stake in Ambev by 7.2% during the second quarter. Moors & Cabot Inc. now owns 61,500 shares of the company's stock worth $154,000 after acquiring an additional 4,150 shares in the last quarter. 8.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ABEV has been the subject of several recent analyst reports. UBS Group upgraded Ambev from a "sell" rating to a "buy" rating in a research note on Thursday, January 12th. StockNews.com started coverage on Ambev in a report on Thursday, January 12th. They set a "buy" rating on the stock. Finally, TheStreet upgraded Ambev from a "c+" rating to a "b" rating in a report on Friday, December 9th.

Ambev Price Performance

Ambev (NYSE:ABEV – Get Rating) last posted its quarterly earnings results on Thursday, October 27th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. The business had revenue of $3.93 billion for the quarter, compared to analysts' expectations of $3.87 billion. Ambev had a return on equity of 15.69% and a net margin of 16.58%. Equities research analysts expect that Ambev S.A. will post 0.16 EPS for the current fiscal year.

Ambev Dividend Announcement

The company also recently declared an annual dividend, which was paid on Monday, January 9th. Investors of record on Wednesday, December 21st were issued a $0.1457 dividend. This represents a yield of 3.8%. The ex-dividend date was Tuesday, December 20th. Ambev's dividend payout ratio is 75.00%.

Ambev Company Profile

(Get Rating)

Ambev SA, through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. The company operates through four segments: Brazil; Central America and the Caribbean; Latin America South; and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Cacique, Presidente, Brahma Light, Presidente Light, Presidente Golden Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, and Budweiser, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

Featured Stories

• Get a free copy of the StockNews.com research report on Ambev (ABEV)
• AMD Is Still One Of The Best Semiconductor Stocks Out There
• Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
• Is The Bottom In For Cyber-Security Stocks?
• Union Pacific, Norfolk Southern Pull into Buying Zone
• Pliant Therapeutics Gaps 34% Higher: More Upside To Come?

Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.